...
search icon
engn-img

enGene Holdings Inc. Common Stock, Common Stock

ENGN

NAQ

$3.82

+$0.08

(2.14%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$198.30M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
53.99K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
-0.37
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$3.61 L
$15.74 H
$3.82

About enGene Holdings Inc. Common Stock, Common Stock

enGene Holdings Inc., through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company that develops genetic medicines to help patients suffering from bladder cancer. Its lead product candidate is detalimogene voraplasmid, a non-viral monotherapy to treat non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS) in patients that have been unresponsive to treatment with Bacillus Calmette-Guérin (BCG). enGene Holdings Inc. is based in Montreal, Canada. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameENGNSectorS&P500
1-Week Return-19.95%-1.02%1.43%
1-Month Return-11.97%-5.31%-1.07%
3-Month Return-45.65%-7.33%-6.61%
6-Month Return-55.16%-6.9%-2%
1-Year Return-75.07%-2.73%10.58%
3-Year Return-61.69%5.53%34.71%
5-Year Return-61.26%39.74%96.96%

Financials

Oct '20Oct '21Oct '22Oct '23Oct '245YR TREND
Total Revenue-----[{"date":"2020-10-31","value":"-","profit":true},{"date":"2021-10-31","value":"-","profit":true},{"date":"2022-10-31","value":"-","profit":true},{"date":"2023-10-31","value":"-","profit":true},{"date":"2024-10-31","value":"-","profit":true}]
Cost of Revenue---175.00K-[{"date":"2020-10-31","value":"-","profit":true},{"date":"2021-10-31","value":"-","profit":true},{"date":"2022-10-31","value":"-","profit":true},{"date":"2023-10-31","value":100,"profit":true},{"date":"2024-10-31","value":"-","profit":true}]
Gross Profit---(175.00K)-[{"date":"2020-10-31","value":"-","profit":true},{"date":"2021-10-31","value":"-","profit":true},{"date":"2022-10-31","value":"-","profit":true},{"date":"2023-10-31","value":-17500000,"profit":false},{"date":"2024-10-31","value":"-","profit":true}]
Gross Margin---(Infinity%)-[{"date":"2020-10-31","value":"-","profit":true},{"date":"2021-10-31","value":"-","profit":true},{"date":"2022-10-31","value":"-","profit":true},{"date":"2023-10-31","value":null,"profit":false},{"date":"2024-10-31","value":"-","profit":true}]
Operating Expenses13.85M15.87M19.43M25.89M62.30M[{"date":"2020-10-31","value":22.24,"profit":true},{"date":"2021-10-31","value":25.47,"profit":true},{"date":"2022-10-31","value":31.18,"profit":true},{"date":"2023-10-31","value":41.55,"profit":true},{"date":"2024-10-31","value":100,"profit":true}]
Operating Income(13.85M)(15.87M)(19.43M)(26.06M)62.30M[{"date":"2020-10-31","value":-22.24,"profit":false},{"date":"2021-10-31","value":-25.47,"profit":false},{"date":"2022-10-31","value":-31.18,"profit":false},{"date":"2023-10-31","value":-41.83,"profit":false},{"date":"2024-10-31","value":100,"profit":true}]
Total Non-Operating Income/Expense(4.86M)10.65M(6.31M)(77.68M)479.00K[{"date":"2020-10-31","value":-45.63,"profit":false},{"date":"2021-10-31","value":100,"profit":true},{"date":"2022-10-31","value":-59.25,"profit":false},{"date":"2023-10-31","value":-729.66,"profit":false},{"date":"2024-10-31","value":4.5,"profit":true}]
Pre-Tax Income(15.07M)(23.44M)(24.44M)(99.90M)55.16M[{"date":"2020-10-31","value":-27.32,"profit":false},{"date":"2021-10-31","value":-42.5,"profit":false},{"date":"2022-10-31","value":-44.31,"profit":false},{"date":"2023-10-31","value":-181.11,"profit":false},{"date":"2024-10-31","value":100,"profit":true}]
Income Taxes4.33M4.90M22.00K17.00K(19.00K)[{"date":"2020-10-31","value":88.54,"profit":true},{"date":"2021-10-31","value":100,"profit":true},{"date":"2022-10-31","value":0.45,"profit":true},{"date":"2023-10-31","value":0.35,"profit":true},{"date":"2024-10-31","value":-0.39,"profit":false}]
Income After Taxes(19.40M)(28.34M)(24.46M)(99.92M)55.18M[{"date":"2020-10-31","value":-35.16,"profit":false},{"date":"2021-10-31","value":-51.35,"profit":false},{"date":"2022-10-31","value":-44.33,"profit":false},{"date":"2023-10-31","value":-181.07,"profit":false},{"date":"2024-10-31","value":100,"profit":true}]
Income From Continuous Operations(15.07M)(23.44M)(24.46M)(99.92M)(55.14M)[{"date":"2020-10-31","value":-1506800000,"profit":false},{"date":"2021-10-31","value":-2344100000,"profit":false},{"date":"2022-10-31","value":-2446200000,"profit":false},{"date":"2023-10-31","value":-9991700000,"profit":false},{"date":"2024-10-31","value":-5514200000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-10-31","value":"-","profit":true},{"date":"2021-10-31","value":"-","profit":true},{"date":"2022-10-31","value":"-","profit":true},{"date":"2023-10-31","value":"-","profit":true},{"date":"2024-10-31","value":"-","profit":true}]
Net Income(15.07M)(23.44M)(24.46M)(99.92M)55.14M[{"date":"2020-10-31","value":-27.33,"profit":false},{"date":"2021-10-31","value":-42.51,"profit":false},{"date":"2022-10-31","value":-44.36,"profit":false},{"date":"2023-10-31","value":-181.2,"profit":false},{"date":"2024-10-31","value":100,"profit":true}]
EPS (Diluted)--0.00(4.71)(1.50)[{"date":"2020-10-31","value":"-","profit":true},{"date":"2021-10-31","value":"-","profit":true},{"date":"2022-10-31","value":100,"profit":true},{"date":"2023-10-31","value":-235430,"profit":false},{"date":"2024-10-31","value":-75085,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

ENGN
Cash Ratio 16.50
Current Ratio 17.16

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

ENGN
ROA (LTM) -25.75%
ROE (LTM) -44.21%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

ENGN
Debt Ratio Lower is generally better. Negative is bad. 0.13
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.87

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

ENGN
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 0.78
Price/FCF NM
EV/R 0.00
EV/Ebitda NM

FAQs

What is enGene Holdings Inc. Common Stock share price today?

enGene Holdings Inc. Common Stock (ENGN) share price today is $3.82

Can Indians buy enGene Holdings Inc. Common Stock shares?

Yes, Indians can buy shares of enGene Holdings Inc. Common Stock (ENGN) on Vested. To buy enGene Holdings Inc. Common Stock from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in ENGN stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of enGene Holdings Inc. Common Stock be purchased?

Yes, you can purchase fractional shares of enGene Holdings Inc. Common Stock (ENGN) via the Vested app. You can start investing in enGene Holdings Inc. Common Stock (ENGN) with a minimum investment of $1.

How to invest in enGene Holdings Inc. Common Stock shares from India?

You can invest in shares of enGene Holdings Inc. Common Stock (ENGN) via Vested in three simple steps:

  • Click on Sign Up or Invest in ENGN stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in enGene Holdings Inc. Common Stock shares
What is enGene Holdings Inc. Common Stock 52-week high and low stock price?

The 52-week high price of enGene Holdings Inc. Common Stock (ENGN) is $15.74. The 52-week low price of enGene Holdings Inc. Common Stock (ENGN) is $3.61.

What is enGene Holdings Inc. Common Stock price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of enGene Holdings Inc. Common Stock (ENGN) is 0.78

What is the Market Cap of enGene Holdings Inc. Common Stock?

The market capitalization of enGene Holdings Inc. Common Stock (ENGN) is $198.30M

What is enGene Holdings Inc. Common Stock’s stock symbol?

The stock symbol (or ticker) of enGene Holdings Inc. Common Stock is ENGN

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top